News&Resources

In a recent Federal Court decision from the District Court of New Jersey, Judge Lifland has ruled on summary judgment that Sandoz’s (Eon Labs) generic version of Neurontin™ (gabapentin), does not infringe U.S. Patent No. 6,054,482 owned by Warner Lambert (Pfizer). In its decision the Court found that Sandoz’s generic […]

The Court of Appeals for the Federal Circuit, in a unanimous decision, affirmed the judgment of the trial court that Eon Labs’ generic version of Itraconazole does not infringe U.S. Patent No. 5,633,015 owned by Janssen Pharmaceutica (a subsidiary of Johnson & Johnson.) In its decision the Federal Circuit agreed […]

In a patent application for streamlining and automating many aspects of home constructions and remodeling, SSJR’s patent prosecution team has succeeded in obtaining reversal of several key claims finally rejected by the patent examiner. The application has since issued as U.S. Patent No. 7,006,977.

SSJR was granted an ex-parte Temporary Restraining Order and Seizure Order on February 24, 2005 on behalf of Cannondale Bicycle Corporation in the Northern District of Illinois against a web-based trademark counterfeiting business. The counterfeiting business used several company names and operated out of numerous locations in multiple states to […]

After successfully convincing the Board of Patent Appeals and Interferences to reverse all rejections issued by the patent examiner in a patent application directed to an electronic document proofing system, SSJR’s patent prosecution team has issued U.S. Patent No. 6,918,082.